Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

27.77
-1.1900-4.11%
Pre-market: 27.76-0.0100-0.04%07:00 EDT
Volume:340.00K
Turnover:9.43M
Market Cap:1.92B
PE:-38.78
High:28.84
Open:28.82
Low:27.33
Close:28.96
52wk High:38.54
52wk Low:18.85
Shares:69.31M
Float Shares:12.94M
Volume Ratio:1.70
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7160
EPS(LYR):-2.5873
ROE:-33.57%
ROA:-13.53%
PB:6.15
PE(LYR):-10.73

Loading ...

Goldman Sachs-Backed Immunotherapy Pioneer Attovia (ATTO.US) Heads to Nasdaq: Targeting $212.5 Million in Top Funding, Adding Fuel to Biotech IPO Boom

Stock News
·
Jul 30

Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome

GlobeNewswire
·
Jul 29

Alzpath: Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease

THOMSON REUTERS
·
Jul 23

Alamar Biosciences Director Ian Ratcliffe Dies; Board Size Reduced to Five

Reuters
·
Jul 16

Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026

GlobeNewswire
·
Jul 15

BofA Securities Adjusts Alamar Biosciences Price Target to $30 From $27

MT Newswires Live
·
Jul 13

Alamar teams with research universities to launch proteomics initiatives

TIPRANKS
·
Jul 13

Alamar Biosciences Launches National Blood Biomarker Initiative for Alzheimer’s Research

Reuters
·
Jul 13

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling

GlobeNewswire
·
Jul 10

Alamar Biosciences Launches First Multiplexed Blood-based Immunoassay for Emtbr-tau, One of Most Important Biomarkers in Alzheimer's Disease Research

THOMSON REUTERS
·
Jul 07

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

GlobeNewswire
·
Jul 07

Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)

TIPRANKS
·
Jun 09

Alamar Biosciences initiated with an Outperform at Leerink

TIPRANKS
·
May 13

BofA Initiates Alamar Biosciences at Neutral With $27 Price Target

MT Newswires Live
·
May 12

Alamar Biosciences, Inc. : Bofa Global Research Initiates Coverage With Neutral Rating and Price Objective $27.00

THOMSON REUTERS
·
May 12

Stifel Initiates Alamar Biosciences at Buy With $28 Price Target

MT Newswires Live
·
May 12

Alamar Biosciences Initiated at Buy by Stifel

Dow Jones
·
May 12

Alamar Biosciences Inc : TD Cowen Initiates Coverage With Buy Rating; Price Target $30

THOMSON REUTERS
·
May 12

Alamar Biosciences Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $35

THOMSON REUTERS
·
May 12

Alamar Biosciences initiated with a Buy at TD Cowen

TIPRANKS
·
May 12